Tag: Drug
Health
Eli Lilly Commits $1B to Get Drug That Could Rival Vertex’s New Non-Opioid Pain Med
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup whose lead program addresses the same target as...
Health
AI Is Finding Broader Use in in Healthcare, and It’s Not Just for Speedy Drug R&D Anymore
In the life sciences community, there’s a lot of discussion about how artificial intelligence is speeding up drug research, enabling big pharmaceutical companies and...
Health
GSK Inflammation Drug Lands New FDA Nod in COPD, Stiffening Competition With Sanofi Med
A GSK drug that targets a pathway behind the lung inflammation in chronic obstructive pulmonary disease, or COPD, has won a long-awaited FDA approval(Opens...
Health
Pfizer Pledges $1.25B for Drug Candidate in Promising But Competitive Area of Immunotherapy
Pfizer’s top cancer drugs are small molecules, but dealmaking has expanded the pharmaceutical giant’s portfolio and pipeline with biologic medicines. Its latest deal puts...
Health
23andMe Bankruptcy Auction Win Adds Big Piece to Regeneron’s Gene-Based Drug R&D Efforts
Regeneron Pharmaceuticals, a company that has been analyzing genetic data as part of its drug research for more than a decade, is augmenting its...
Health
BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease
BioMarin Pharmaceutical is building up its pipeline with the acquisition of Inozyme Pharma in a $270 million deal centered on an enzyme replacement therapy...